ENZON PHARMACEUTICALS, INC. Quarterly Operating Margin in % from Q4 2019 to Q3 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Enzon Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q3 2023.
  • Enzon Pharmaceuticals, Inc. Operating Margin for the quarter ending September 30, 2023 was -4K %, a 10.2% decline year-over-year.
  • Enzon Pharmaceuticals, Inc. annual Operating Margin for 2022 was -3.97K %, a 5833% decline from 2021.
  • Enzon Pharmaceuticals, Inc. annual Operating Margin for 2021 was -66.9 %, a 97.3% increase from 2020.
  • Enzon Pharmaceuticals, Inc. annual Operating Margin for 2020 was -2.51K %, a 434% decline from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -4K -369 -10.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -3.98K -329 -9.01% Apr 1, 2023 Jun 30, 2023
Q1 2023 -3.92K -3.68K -1516% Jan 1, 2023 Mar 31, 2023
Q4 2022 -3.97K -3.9K -5833% Oct 1, 2022 Dec 31, 2022
Q3 2022 -3.63K -3.53K -3780% Jul 1, 2022 Sep 30, 2022
Q2 2022 -3.65K -3.53K -3008% Apr 1, 2022 Jun 30, 2022
Q1 2022 -243 +1.74 +0.71% Jan 1, 2022 Mar 31, 2022
Q4 2021 -66.9 +2.44K +97.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -93.5 +1.61K +94.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -118 +1.62K +93.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -245 +80.1 +24.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -2.51K -2.04K -434% Oct 1, 2020 Dec 31, 2020
Q3 2020 -1.7K Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.74K Apr 1, 2020 Jun 30, 2020
Q1 2020 -325 Jan 1, 2020 Mar 31, 2020
Q4 2019 -470 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.